A detailed history of Atom Investors LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Atom Investors LP holds 446 shares of LLY stock, worth $404,392. This represents 0.04% of its overall portfolio holdings.

Number of Shares
446
Holding current value
$404,392
% of portfolio
0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $264,121 - $353,356
446 New
446 $346,000
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $207,638 - $277,636
592 New
592 $277,000
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $333,447 - $388,532
1,037 New
1,037 $379,000
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $483,223 - $639,421
-3,704 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $541,598 - $626,457
3,704 New
3,704 $548,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.